In consequence, we found that the top five pathways were IL-17 signaling pathway, TNF signaling pathway, Non-alcoholic fatty liver disease, NF-kappa B signaling pathway, and Insulin resistance, respectively. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatotic liver disease.